17 November 2026Research and development in Australia
Australian R&D
Research funding

Research commercialisation revenue rises 39% to $336 million as support is wound back

Australian research organisations earned $336 million from commercialisation in 2025, KCA's survey shows, as two federal programs were wound back.

By Australian R&D staff · 21 October 2026 · 2 min read

Australian universities and public research organisations earned $336 million from commercialising their research in 2025, up 39% on the year before, according to Knowledge Commercialisation Australasia's annual survey (KCA). They created 102 new companies and signed 766 licence, option and assignment deals, up 25%.

The figures arrive as two federal programs that helped research reach the market have been wound back.

The numbers

Australia20242025
Commercialisation revenue$241 million$336 million
New spinouts and start-ups90102
Licences, options and assignments611766
Industry research contracts$1 billion$960 million

Source: KCA Survey of Commercialisation Outcomes from Public Research (SCOPR). Participation is voluntary and self-reported, and 56 Australian organisations responded for 2025 against 58 for 2024, so the year-on-year change is not exactly like for like. $336 million is the highest annual figure in KCA's five years of published data.

One deal did a lot of the work. The University of Queensland led on revenue, at $165 million, boosted by Vicebio, a UQ spinout acquired by Sanofi. CSIRO had the most active deals, at more than 500, and UNSW created the most new start-ups and spinouts, with 25.

“Companies are trusting universities and research institutes with their big ideas,” said John Grace, who founded the survey.

The cuts

The May Budget cancelled $800 million in uncommitted funding for Australia's Economic Accelerator, half the program's original outlay (Future Campus). The Industry Growth Program, which gave matched grants of up to $5 million, was paused to new applicants from 12 May (SmartCompany).

KCA chair Kate Taylor warned that “the pressure of reduced funding is being felt at every stage, from research to market”. “The loss of Australia’s Economic Accelerator, pausing of the Industry Growth Program and uncertainty regarding the R&D tax incentive and CGT has done great damage,” she said (KCA).

Founders told SmartCompany the same. Sam Ringwaldt of Conry Tech described being “left in this like, no man’s land of no capital”, and Ryan Nelson of Sydney's Refilled said: “We’re left with no alternative but to start looking overseas and manufacturing offshore.” (SmartCompany, October 2026)

For the other big change on the way, see our analysis of the R&D Tax Incentive changes.

More news